• Product NameRecombinant Human VHL
• Brief DescriptionRecombinant Protein
• Immunogen DescriptionFull length fusion protein
• Target Namevon Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
• Alternative Names    RCA1; VHL1; pVHL; HRCA1
• Accession No. Swissprot:P40337
  Gene Accession:BC058831
• UniprotP40337
• Gene ID7428;
• Storage -20~-80˚C, pH 7.6 PBS

Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity.?

Note: For in vitro research use only, not for diagnostic or therapeutic use. This product is not a medical device.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting